XML 49 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income taxes [Abstract]  
Components of Income Tax Expense (Benefit)
The components of the income tax expense (benefit) are as follows:

   
December 31,
 
(In thousands)
 
2023
   
2022
 
Current:
           
Federal
 
$
(1
)
 
$
149
 
State
   
51
     
110
 
Foreign
   
85
     
(83
)
     
135
     
176
 
Deferred:
               
Federal
   
825
     
(1,924
)
State
   
132
     
(217
)
Foreign
   
63
     
 
     
1,020
     
(2,141
)
Income tax expense (benefit)
 
$
1,155
   
$
(1,965
)
Deferred Tax Assets and Liabilities
Deferred income taxes arise from temporary differences between the tax basis of assets and liabilities and their reported amounts in the Consolidated Financial Statements.  Our deferred tax assets and liabilities were comprised of the following:

 
December 31,
 
(In thousands)
 
2023
   
2022
 
Deferred tax assets:
           
Federal net operating losses
 
$
   
$
2,297
 
Foreign net operating losses
   
733
     
676
 
State net operating losses
   
84
     
149
 
Accrued severance
   
165
     
 
Capitalized R&D expenses
   
3,127
     
1,708
 
Inventory reserves
   
896
     
648
 
Deferred revenue
   
31
     
41
 
Warranty reserve
   
24
     
17
 
Stock compensation expense
   
790
     
769
 
Other accrued compensation
   
404
     
222
 
R&D credit carryforward
   
695
     
1,238
 
Other Assets
    360        
Other liabilities and reserves
   
     
463
 
Gross deferred tax assets
   
7,309
     
8,228
 
Valuation allowance
   
(719
)
   
(656
)
Net deferred tax assets
   
6,590
     
7,572
 
                 
Deferred tax liabilities:
               
Depreciation and amortization
   
237
     
196
 
Other
   
49
     
49
 
Net deferred tax liabilities
   
286
     
245
 
Total net deferred tax assets
 
$
6,304
   
$
7,327
 
Valuation Allowance on Deferred Tax Assets
As of December 31, 2023 and 2022, we had a $719 thousand and $656 thousand, respectively, of valuation allowances on our net operating loss carryforwards. The following table summarizes the activity recorded in the valuation allowance on the deferred tax assets:

   
Year Ended December 31,
 
(In thousands)
 
2023
   
2022
 
Balance, beginning of period
 
$
656
   
$
733
 
Subtractions released to income tax provisions
   
     
(77
)
Additions charged to income tax provision
   
63
     
 
Balance, end of period
 
$
719
   
$
656
 
Statutory to Effective Tax Rate Reconciliation
Differences between the U.S. statutory federal income tax rate and our effective income tax rate are analyzed below:

   
Year Ended December 31,
 
 
2023
   
2022
 
             
Federal statutory rate
   
21.0
%
   
21.0
%
R&D credit
   
(5.9
)
   
4.3
 
Foreign-derived intangible income deduction
    (1.7 )      
Stock award excess tax benefit
   
0.4
     
 
State income taxes, net of federal income taxes
   
2.5
     
1.1
 
Business meals and entertainment
   
0.3
     
 
Executive compensation limitation
   
0.6
     
 
Uncertain tax positions
   
0.5
     
(0.5
)
Stock option cancellations
   
0.6
     
(1.9
)
Valuation allowance and tax accruals
   
1.0
     
1.0
 
Other
   
0.3
     
(0.1
)
Effective tax rate
   
19.6
%
   
24.9
%
Unrecognized Tax Benefits
We had $197 thousand and $142 thousand of total gross unrecognized tax benefits at December 31, 2023 and 2022, respectively that, if recognized, would favorably affect the effective income tax rate in any future periods.  We are not aware of any events that could occur within the next twelve months that could cause a significant change in the total amount of unrecognized tax benefits.  A tabular reconciliation of the gross amounts of unrecognized tax benefits at the beginning and end of the year is as follows:

 
December 31,
 
(In thousands)
 
2023
   
2022
 
Balance, beginning of period
 
$
142
   
$
144
 
Tax positions taken during the current period
   
83
     
26
 
Lapse of statute of limitations
   
(28
)
   
(28
)
Balance, end of period
 
$
197
   
$
142